Could Cigna Exiting the Individual Market be an Indictment of ICHRA?
Cigna's exit from the ACA individual market is causing one healthcare expert to question the long-term potential of ICHRA.
Cigna's exit from the ACA individual market is causing one healthcare expert to question the long-term potential of ICHRA.
Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it. Experts say this problem could force the industry to redefine the boundaries of access, accountability and trust in data sharing.
Matt Holt, former New Mountain Capital executive, is exploring a $30 billion deal to combine five health tech startups into a single platform called Thoreau. The venture would set out to simplify and integrate services across payers, providers and data — and if completed, it would rank among the largest private equity-backed health tech companies ever. Time will tell if this massive consolidation ever gets completed or translates into real value — or if it's just another bet on scale.
Some large health systems are experimenting with selling their internal capabilities — such as IT support, revenue cycle management and call center operations — to smaller hospitals as a new revenue stream. While the approach is still rare, it has the potential to help health systems monetize their expertise and infrastructure, one healthcare consultant said.
Amazon Pharmacy recently launched a new caregiver feature and expanded PillPack to Medicare Part D. The company says the updates will support medication adherence.
WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly changing weight-loss environment spurred by the rising popularity of GLP-1s, experts said.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are putting off mergers for the time being, though some are forming joint ventures as a defense mechanism against financial uncertainty. Many are instead shedding assets to cope with the current macroeconomic environment.
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could worsen care quality and force hospitals to make tough financial decisions — from cutting services to delaying tech upgrades.
UnitedHealth Group's shares fell by over 22% on Thursday after its first quarter earnings. This is largely due to challenges in its Medicare Advantage business.
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.
Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has focused more on supporting clinicians, while the previous Trump administration favored corporations. Additionally, one expert noted that this case differs from other antitrust lawsuits because it does not seem to focus on a potential price increase.
A new Mercer report predicts there will be a national surplus of about 30,000 nurses by 2028. Though an overall surplus is projected nationally, there will still be significant shortages of nursing labor in a handful of states, as well as most of the country’s rural areas. To solve this issue, providers need to recruit from wider labor pools, minimize nurses’ nonclinical tasks and prioritize creating a more supportive work environment.
Health systems' financial results suggest the start of sustained recovery, but persistent challenges remain, including rising expenses and less-than-ideal reimbursement rates from payers.
Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space.
CVS Health overtook Walgreens as the most popular drugstore retailer, a new report found. However, there is no saying for sure if CVS will keep this lead.